Long noncoding RNA DANCR contributes to docetaxel resistance in prostate cancer through targeting the miR-34a-5p/JAG1 pathway

Background: Chemotherapy is one of the available options for prostate cancer (PC). However, the acquisition of chemoresistance has become a major cause of chemotherapy failure. The long noncoding RNA DANCR is demonstrated to serve as an oncogene in various human cancers, including PC. However, the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yongliang, Fan, Bo, Ren, Zongtao, Liu, Bin, Wang, Yanchao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636610/
https://www.ncbi.nlm.nih.gov/pubmed/31371987
http://dx.doi.org/10.2147/OTT.S197009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636610/
https://www.ncbi.nlm.nih.gov/pubmed/31371987
http://dx.doi.org/10.2147/OTT.S197009

Ejemplares similares